Serum levels of elastin-derived peptides in patients with ruptured and asymptomatic abdominal aortic aneurysms

European Journal of Vascular and Endovascular Surgery

Volumn 22, Issue 1, 2001, Pages 48-52

  Petersen, E ^a   Gineitis, A ^b   Wagberg F ^a   Angquist K A ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Abdominal aortic aneurysms; Asymptomatic; Elastin derived peptides; Rupture

Indexed keywords

ELASTIN; ELASTIN DERIVED PEPTIDE; PEPTIDE; UNCLASSIFIED DRUG;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RABBIT; RISK; SYMPTOM;

EID: 0034924117     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejvs.2001.1404     Document Type: Article

References (46)

1. Pathophysiology and pathogenesis of aortic aneurysms. Current concepts
2. Adventitial elastolysis is a primary event in aneurysm formation
3. Metalloproteinases in degenerative aortic disease
4. Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response
5. Smooth muscle cell elastase, atherosclerosis, and abdominal aortic aneurysms
6. Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms
7. Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm
8. Matrix metalloproteinases in abdominal aortic aneurysm: Characterization, purification, and their possible sources
9. Elastin degradation in abdominal aortic aneurysms
10. Cellular, enzymatic, and genetic factors in the pathogenesis of abdominal aortic aneurysms
11. Modifications of the extracellular matrix of aneurysmal abdominal aortas as a function of their size
12. Ruptured arteriosclerotic abdominal aortic aneurysms. A pathologic and clinical study
13. Elastin structure, biosynthesis, and relation to disease states
14. Solid-phase radioimmunoassay for estimation of elastin peptides in human sera
15. Immunologic measurement of elastin-derived peptides in human serum
16. Plasma elastin-derived peptide levels in normal adults, children, and emphysematous subjects. Physiologic and computed tomographic scan correlates
17. Comparison of elastin peptide concentrations in body fluids from healthy volunteers, smokers, and patients with chronic obstructive pulmonary disease
18. Serum-elastin-peptides as a predictor of expansion of small abdominal aortic aneurysms
19. The production of monoclonal antibodies to membrane proteins
20. Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of D-aspartate and nuclear weapons-related radiocarbon
21. Proteolysis of insoluble elastin
22. [Natural history of abdominal aortic aneurysm with and without concomitant chronic obstructive pulmonary disease]
23. Collagen and elastin gene expression in aortic aneurysms
24. Variables that affect the expansion rate and outcome of small abdominal aortic aneurysms
25. Actuarial analysis of variables associated with rupture of small abdominal aortic aneurysms
26. Predictors of death from aortic aneurysm among middle-aged men: The Whitehall study
27. The aneurysm detection and management study screening program: Validation cohort and final results
28. Smoking, lung function and the prognosis of abdominal aortic aneurysm
29. Altered aortic protease and antiprotease activity in patients with ruptured abdominal aortic aneurysms
30. Activity of matrix metalloproteinase-2 and -9 in abdominal aortic aneurysms. Relation to size and rupture
31. Elastin-derived peptide induces monocyte chemotaxis by increasing intracellular cyclic GMP level and activating cyclic GMP dependent protein kinase
32. Regulation of matrix metalloproteinase-2 (gelatinase A, MMP-2), membrane-type matrix metalloproteinase-1 (MT1-MMP) and tissue inhibitor of metalloproteinases-2 (TIMP-2) expression by elastin-derived peptides fibrosarcoma cell line
33. Survival in patients with abdominal aortic aneurysms. Comparison between operative and nonoperative management
34. Expansion pattern and risk of rupture of abdominal aortic aneurysms that were not operated on
35. Clinical fate of the patient with asymptomatic abdominal aortic aneurysm and unfit for surgical treatment
36. The selective management of small abdominal aortic aneurysms: The Kingston study
37. Natural history of patients with abdominal aortic aneurysm
38. Natural history of abdominal aortic aneurysm: A survey of 63 patients treated nonoperatively
39. Ruptured abdominal aortic aneurysm: A population-based study
40. An evaluation of new methods of expressing aortic aneurysm size: Relationship to rupture
41. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms
42. Mortality in ruptured abdominal aortic aneurysms
43. Ruptured abdominal aortic aneurysm: A population-based study
44. Relationship between abdominal aortic aneurysm wall compliance and clinical outcome: A preliminary analysis
45. Amino-terminal propeptide of type III procollagen in the follow-up of patients with abdominal aortic aneurysms
46. Intraluminal thrombus predicts rupture of an abdominal aortic aneurysm